Page last updated: 2024-10-27

furosemide and Lung Adenocarcinoma

furosemide has been researched along with Lung Adenocarcinoma in 1 studies

Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.

Research Excerpts

ExcerptRelevanceReference
"However, she experienced recurrence with positive T790 M, and osimertinib (80 mg/day) was administered as the 2nd line therapy."1.56Osimertinib induced cardiomyopathy: A case report. ( Ishikawa, K; Kagamu, H; Kaira, K; Shinomiya, S; Yamaguchi, O, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Shinomiya, S1
Kaira, K1
Yamaguchi, O1
Ishikawa, K1
Kagamu, H1

Other Studies

1 other study available for furosemide and Lung Adenocarcinoma

ArticleYear
Osimertinib induced cardiomyopathy: A case report.
    Medicine, 2020, Sep-25, Volume: 99, Issue:39

    Topics: Acrylamides; Adenocarcinoma of Lung; Adrenergic beta-Antagonists; Afatinib; Aged; Angiotensin-Conver

2020